Wright gains biologic foot-and-ankle line from AM Surgical
This article was originally published in Clinica
Wright Medical has bolstered its orthobiologics product portfolio by buying the foot and ankle surgery unit from AM Surgical, a firm specialising in endoscopic soft tissue release technology. The Arlington, Tennessee-based firm will pay AM an up-front fee of $2.1m for its whole line of foot and ankle-related products, while potential additional payments of up to $700,000 may follow depending on the future financial performance of the acquired technology. Wright has previously been marketing AM’s foot and ankle technology under an exclusive worldwide distribution deal signed in October 2007 (see Clinica 1277, p 14). Wright expects international commercialisation of the products during 2009.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals